Format
Sort by

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 1334

1.

How strong is the evidence that Parkinson's disease is a prion disorder?

Brundin P, Ma J, Kordower JH.

Curr Opin Neurol. 2016 Aug;29(4):459-66. doi: 10.1097/WCO.0000000000000349. Review.

PMID:
27257944
2.

Constitutive translation of human α-synuclein is mediated by the 5'-untranslated region.

Koukouraki P, Doxakis E.

Open Biol. 2016 Apr;6(4):160022. doi: 10.1098/rsob.160022.

3.

[SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].

Emelyanov AK, Andoskin PA, Miliukhina IV, Timofeeva AA, Yakimovskii AF, Senkevich KA, Nikolaev MA, Pchelina SN.

Tsitologiia. 2016;58(2):99-104. Russian.

PMID:
27228655
4.

Protective effects and mechanisms of Ndfipl on SH-SY5Y cell apoptosis in an in vitro Parkinson's disease model.

Xing LF, Guo HP, Wang DT, Sun LH, Pan SY.

Genet Mol Res. 2016 Apr 25;15(2). doi: 10.4238/gmr.15026963.

5.

Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.

Tatenhorst L, Eckermann K, Dambeck V, Fonseca-Ornelas L, Walle H, Lopes da Fonseca T, Koch JC, Becker S, Tönges L, Bähr M, Outeiro TF, Zweckstetter M, Lingor P.

Acta Neuropathol Commun. 2016 Apr 22;4:39. doi: 10.1186/s40478-016-0310-y.

6.

α-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals.

Xu J, Wu XS, Sheng J, Zhang Z, Yue HY, Sun L, Sgobio C, Lin X, Peng S, Jin Y, Gan L, Cai H, Wu LG.

J Neurosci. 2016 Apr 20;36(16):4408-14. doi: 10.1523/JNEUROSCI.3627-15.2016.

7.

Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.

Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, Goldmann J, Myers RH, Young RA, Jaenisch R.

Nature. 2016 May 5;533(7601):95-9. doi: 10.1038/nature17939.

8.

Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration.

Davis MY, Trinh K, Thomas RE, Yu S, Germanos AA, Whitley BN, Sardi SP, Montine TJ, Pallanck LJ.

PLoS Genet. 2016 Mar 28;12(3):e1005944. doi: 10.1371/journal.pgen.1005944.

9.

Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.

Vivacqua G, Latorre A, Suppa A, Nardi M, Pietracupa S, Mancinelli R, Fabbrini G, Colosimo C, Gaudio E, Berardelli A.

PLoS One. 2016 Mar 24;11(3):e0151156. doi: 10.1371/journal.pone.0151156.

10.

Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.

Ren WQ, Tian ZM, Yin F, Sun JZ, Zhang JN.

Pharmazie. 2016 Feb;71(2):51-5.

PMID:
27004367
11.

Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores.

Hu R, Diao J, Li J, Tang Z, Li X, Leitz J, Long J, Liu J, Yu D, Zhao Q.

Sci Rep. 2016 Feb 11;6:20776. doi: 10.1038/srep20776.

12.

The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.

Benskey MJ, Perez RG, Manfredsson FP.

J Neurochem. 2016 May;137(3):331-59. doi: 10.1111/jnc.13570. Review.

13.

Preparation and Characterization of Stable α-Synuclein Lipoprotein Particles.

Eichmann C, Campioni S, Kowal J, Maslennikov I, Gerez J, Liu X, Verasdonck J, Nespovitaya N, Choe S, Meier BH, Picotti P, Rizo J, Stahlberg H, Riek R.

J Biol Chem. 2016 Apr 15;291(16):8516-27. doi: 10.1074/jbc.M115.707968.

PMID:
26846854
14.

Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.

Gallea JI, Sarroukh R, Yunes-Quartino P, Ruysschaert JM, Raussens V, Celej MS.

Biochim Biophys Acta. 2016 May;1864(5):501-10. doi: 10.1016/j.bbapap.2016.01.011.

PMID:
26845568
15.

Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells.

Wang K, Huang J, Xie W, Huang L, Zhong C, Chen Z.

Diagn Pathol. 2016 Jan 29;11:15. doi: 10.1186/s13000-016-0459-5.

16.

Structural disorder of monomeric α-synuclein persists in mammalian cells.

Theillet FX, Binolfi A, Bekei B, Martorana A, Rose HM, Stuiver M, Verzini S, Lorenz D, van Rossum M, Goldfarb D, Selenko P.

Nature. 2016 Feb 4;530(7588):45-50. doi: 10.1038/nature16531.

PMID:
26808899
17.

Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites.

Binolfi A, Limatola A, Verzini S, Kosten J, Theillet FX, Rose HM, Bekei B, Stuiver M, van Rossum M, Selenko P.

Nat Commun. 2016 Jan 25;7:10251. doi: 10.1038/ncomms10251.

18.

Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.

Wang G, Huang Y, Chen W, Chen S, Wang Y, Xiao Q, Liu J, Fung VS, Halliday G, Chen S.

Parkinsonism Relat Disord. 2016 Mar;24:89-94. doi: 10.1016/j.parkreldis.2015.12.018.

PMID:
26776090
19.

PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

PLoS One. 2016 Jan 12;11(1):e0146905. doi: 10.1371/journal.pone.0146905.

20.

The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.

Shahmohammadibeni N, Rahimi-Aliabadi S, Jamshidi J, Emamalizadeh B, Shahmohammadibeni HA, Zare Bidoki A, Akhavan-Niaki H, Eftekhari H, Abdollahi S, Shekari Khaniani M, Shahmohammadibeni M, Fazeli A, Motallebi M, Taghavi S, Ahmadifard A, Shafiei Zarneh AE, Andarva M, Dadkhah T, Khademi E, Alehabib E, Rahimi M, Tafakhori A, Atakhorrami M, Darvish H.

Neurol Sci. 2016 May;37(5):731-6. doi: 10.1007/s10072-015-2420-x.

PMID:
26732583
Items per page

Supplemental Content

Support Center